MONTREAL, April 30, 2012 /CNW Telbec/ - Alain Brunet and Emmanuel Triassi join the IRCM Foundation's Board of Directors. Their appointments were confirmed last week during a Board meeting.
"The IRCM Foundation is proud to welcome these two new members to its Board," said Alain Mayrand, President of the IRCM Foundation. "Their expertise and numerous accomplishments represent important assets to our Foundation."
"We are proud to join the IRCM Foundation's Board, and thereby support one of the leading biomedical research centres in the country," added Mr. Brunet and Mr. Triassi. "We believe it is important to contribute to the advancement of health research and to support an institution built on academic and scientific excellence."
About Alain Brunet
Alain Brunet is Senior Vice-President, Insurance, at National Bank Financial Group, and President of National Bank Insurance. As such, Mr. Brunet is entirely responsible for insurance services and products offered by affiliated life and general insurance brokers. His mandate consists of developing and increasing these strategic activities for the organization. With over 30 years of experience, Mr. Brunet has also worked at Standard Life, where he held the position of Senior Vice-President, Retail, and member of the Executive Committee. With a degree in actuarial science from Université Laval, Mr. Brunet completed the Program for Management Development at Harvard Business School in 1995. He is a Fellow of the Society of Actuaries and of the Canadian Institute of Actuaries. He currently co-chairs the fundraising campaign at the Centre hospitalier régional de Trois-Rivières (CHRTR).
About Emmanuel Triassi
Founding President and CEO of Groupe TEQ, Emmanuel Triassi received a bachelor's degree in civil engineering, a Master's in engineering, project management and construction, and is a certified Corporate Director. He is a member of the Ordre des ingénieurs du Québec, the Project Management Institute, and the Économiste en construction agree. As a researcher and supervisor, Mr. Triassi actively participated in numerous research projects and spoke at conferences on innovative project management methods. He also acted as assistant professor at McGill University. Mr. Triassi chaired the Royal Canadian Mint's Board of Directors, and sat on the Boards of Directors at Hydro-Québec, Théâtre du Nouveau Monde, and the Marguerite-Bourgeoys Museum. He is a Governor of the Italian-Canadian Community Foundation. Mr. Triassi currently co-chairs the IRCM Foundation's major Give for Life fundraising campaign.
IRCM Foundation's Board of Directors
Serge A. Boileau, President, Commission des services électriques de Montréal; Normand Brathwaite, host; André J.P. Couillard, Vice-President, Executive Search, Optimum Talent; Jean-Pierre Desrosiers, Partner, Fasken Martineau DuMoulin; Marinella Ermacora, Senior Vice-President, Business Solutions, Fujitsu Canada Inc.; Jacques Gauthier, Corporate Director; Louise Lambert-Lagacé, Chairwoman of the IRCM Board of Directors, and President, La clinique de nutrition Louise Lambert-Lagacé et associées; Reford MacDougall, Special Advisor to the President, Montreal Economic Institute; Alain Mayrand (Chairman of the Board), Corporate Director; Tarik Möröy, President and Scientific Director, IRCM; J.-Robert Ouimet, Chairman of the Board of Directors and CEO, Holding O.C.B. Inc., Cordon Bleu International Ltd, Ouimet Tomasso Inc.; Joseph Paulin, President, Preston Phipps.
About the IRCM and its Foundation
The Institut de recherches cliniques de Montréal (IRCM) (www.ircm.qc.ca) is a renowned biomedical research institution located in the heart of Montréal's university district. Founded in 1967, it is currently comprised of 36 research units. The IRCM is affiliated with the Université de Montréal, and also maintains a long-standing association with McGill University. The IRCM Clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). Also created in 1967, the IRCM Foundation (www.ircm.qc.ca/fondation) raises funds to support the Institut. It is currently in the midst of a major fundraising campaign, Give for Life, which aims to support the IRCM's research priorities in upcoming years. The campaign's objective has been set at 15 million dollars.
For further information: